MedPath
HSA Approval

STREPSILS CHESTY COUGH LOZENGE

SIN11716P

STREPSILS CHESTY COUGH LOZENGE

STREPSILS CHESTY COUGH LOZENGE

November 15, 2001

RECKITT BENCKISER (SINGAPORE) PTE LTD

RECKITT BENCKISER (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRECKITT BENCKISER (SINGAPORE) PTE LTD
Licence HolderRECKITT BENCKISER (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

LOZENGE

ORAL

Medical Information

R05CB06

ambroxol

Manufacturer Information

RECKITT BENCKISER (SINGAPORE) PTE LTD

RECKITT BENCKISER HEALTHCARE MANUFACTURING (THAILAND) LTD

Active Ingredients

AMBROXOL HCl

15 mg

Ambroxol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

STREPSILS CHESTY COUGH LOZENGE - HSA Approval | MedPath